Wellness clinical trials

Explore recruiting wellness clinical trials.

Recruiting wellness studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Wellness trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switch)

Italy, Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase III Long-Term Extension Trial with Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants with Major Depressive Disorder (EXTEND)

Greece, Poland, Ireland, Germany, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing 2 Active Doses of CYB003 and Placebo in Eligible Participants with Major Depressive Disorder (EMBRACE)

Poland, Ireland, Greece, Czechia, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Monotherapy Study of the Efficacy, Safety, and Tolerability of SPT-300 in Adults with Major Depressive Disorder (MDD), with or without Anxious Distress

Bulgaria, Slovakia, Czechia, Germany, Hungary, Romania +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults with Major Depressive Disorder, With or Without Anxious Distress

Bulgaria, Czechia, Germany, Poland, Hungary, Slovakia +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study (Part A) with a 40 Week Open-Label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults with Generalized Anxiety Disorder - Panorama

France, Czechia, Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Wellness trials by city

Wellness in Toronto Wellness in Vancouver Wellness in Montreal Wellness in Calgary Wellness in Edmonton Wellness in Ottawa Wellness in Winnipeg Wellness in Quebec City Wellness in Hamilton Wellness in Kitchener Wellness in London Wellness in Halifax Wellness in New York Wellness in Los Angeles Wellness in Chicago Wellness in Houston

Wellness clinical trials

Recruiting wellness studies right now

My Health Coach App RCT

Assessment of the Accuracy of Patient Specific Plates for Correction of Maxillary Cant in Facial Asymmetry

Young Adult Education on Alcohol & Health

Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

Isometric Handgrip Training Frequency and Blood Pressure in People With Hypertension

tAN for First Responders

Cardiometabolic Health Intervention Using Movement-to-Music Exercise

Improving Caregiver Engagement in Early Interventions

Impact of Satiating Compounds and Hypocaloric Diet on Weight, Cardiometabolic and Osteoarticular Health in Obesity

A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

Also recruiting in Europe

Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switch)

A Phase III Long-Term Extension Trial with Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants with Major Depressive Disorder (EXTEND)

An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing 2 Active Doses of CYB003 and Placebo in Eligible Participants with Major Depressive Disorder (EMBRACE)

A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Monotherapy Study of the Efficacy, Safety, and Tolerability of SPT-300 in Adults with Major Depressive Disorder (MDD), with or without Anxious Distress

A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults with Major Depressive Disorder, With or Without Anxious Distress

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study (Part A) with a 40 Week Open-Label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults with Generalized Anxiety Disorder - Panorama

Wellness trials by city

Other conditions

Wellness clinical trials

Recruiting wellness studies right now

My Health Coach App RCT

Assessment of the Accuracy of Patient Specific Plates for Correction of Maxillary Cant in Facial Asymmetry

Young Adult Education on Alcohol & Health

Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

Isometric Handgrip Training Frequency and Blood Pressure in People With Hypertension

tAN for First Responders

Cardiometabolic Health Intervention Using Movement-to-Music Exercise

Improving Caregiver Engagement in Early Interventions

Impact of Satiating Compounds and Hypocaloric Diet on Weight, Cardiometabolic and Osteoarticular Health in Obesity

A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

Also recruiting in Europe

Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switch)

A Phase III Long-Term Extension Trial with Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants with Major Depressive Disorder (EXTEND)

An Efficacy and Safety, Phase III, Multi-center, Double-Blind, Randomized Controlled Study Comparing 2 Active Doses of CYB003 and Placebo in Eligible Participants with Major Depressive Disorder (EMBRACE)

A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Monotherapy Study of the Efficacy, Safety, and Tolerability of SPT-300 in Adults with Major Depressive Disorder (MDD), with or without Anxious Distress

A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults with Major Depressive Disorder, With or Without Anxious Distress

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study (Part A) with a 40 Week Open-Label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults with Generalized Anxiety Disorder - Panorama

Wellness trials by city

Other conditions

A Phase III Long-Term Extension Trial with Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants with Major Depressive Disorder (EXTEND)